Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,427
Deep Brain Stimulation Surgery for Movement Disorders
for
Parkinson's Disease, Essential Tremor, Dystonia
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Sex: All
Age: 18 - 70+
Code: NCT01581580
Recruiting
Characterization of Nociception Phenotype in Individuals With Intellectual Disability
for
Intellectual Disability
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 8 - 30
Code: NCT05473429
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
for
Type B Aortic Dissection
Location: Scarborough ME, Boston MA, Worcester MA, Hartford CT,
Sponsor: Duke University
Sex: All
Age: 21+
Code: NCT06087029
Recruiting
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
for
CAD
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 18 - 70+
Code: NCT03331380
Recruiting
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT04485260
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma